World's Best Scientists 2026 revealed!
Current Hematologic Malignancy Reports
H-index 12

Current Hematologic Malignancy Reports

1558-8211

Published by: Springer

https://www.springer.com/journal/11899

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Medicine 2274 23 27 11

Additional Metrics

Number of Best Scientists*: 26
Documents by Best Scientists*: 29
Top 100 Ranked Scientists*: 0
SCIMAGO H-index: 48
SCIMAGO SJR: 1.123
Impact Factor: 3.3

Overview

Top Research Topics at Current Hematologic Malignancy Reports?

Current Hematologic Malignancy Reports mainly deals with areas of study such as Internal medicine, Hematology, Oncology, Immunology and Disease. Many of the studies tackled connect Internal medicine with a similar field of study like Intensive care medicine. The concepts on Intensive care medicine presented in Current Hematologic Malignancy Reports can also apply to other research fields, including Geriatrics gerontology and Quality of life (healthcare).

The research on Hematology featured in Current Hematologic Malignancy Reports combines topics in other fields like Cancer research, Chemotherapy, Myelodysplastic syndromes, Lymphoma and Multiple myeloma. Current Hematologic Malignancy Reports explores issues in Cancer research which can be linked to other research areas like Tyrosine kinase and T cell. In addition to Oncology research, it aims to explore topics under Hematopoietic stem cell transplantation, Surgery, Lenalidomide and Minimal residual disease.

It explores topics in Lenalidomide which can be helpful for research in disciplines like Thalidomide and Bortezomib. The journal investigates Immunology research which frequently intersects with Stem cell. It features Disease research that overlaps with concepts in Bioinformatics.

  • Internal medicine (72.06%)
  • Hematology (60.86%)
  • Oncology (39.14%)

What are the most cited papers published in the journal?

  • Post-Transplant Lymphoproliferative Disease (PTLD): Risk Factors, Diagnosis, and Current Treatment Strategies (155 citations)
  • Bruton’s Tyrosine Kinase (BTK) Inhibitors in Clinical Trials (81 citations)
  • Extranodal NK/T Cell Lymphoma, Nasal Type (ENKTL-NT): An Update on Epidemiology, Clinical Presentation, and Natural History in North American and European Cases (81 citations)

Research areas of the most cited articles at Current Hematologic Malignancy Reports:

The main points discussed in the published papers deal with Internal medicine, Hematology, Immunology, Leukemia and Cancer research. Many of the studies tackled in the journal papers connect Internal medicine with a similar field of study like Oncology. While work presented in the published articles provide substantial information on Immunology, it also covers topics in Stem cell and Transplantation.

What topics the last edition of the journal is best known for?

  • Cancer
  • Internal medicine
  • Disease

The previous edition focused in particular on these issues:

The main points discussed in Current Hematologic Malignancy Reports deals with Internal medicine, Hematology, Oncology, Disease and Intensive care medicine. The Internal medicine research presented places emphasis on topics like Clinical trial, Myeloid leukemia, Lenalidomide, Multiple myeloma and Lymphoma. While Hematology is the focus of the journal, it also provided insights into the studies of Myeloid, Cancer research, Mantle cell lymphoma, Targeted therapy and Chronic myelomonocytic leukemia.

The studies in Oncology featured incorporate elements of Young adult, Brentuximab vedotin, Minimal residual disease, Venetoclax and Chimeric antigen receptor. Disease research presented in it encompasses a variety of subjects, including Myeloproliferative neoplasm, Imatinib, Computational biology and DNA sequencing. While work presented in it provided substantial information on Intensive care medicine, it also covered topics in Geriatrics gerontology, Good death, Palliative care, Hospice care and Tyrosine-kinase inhibitor.

The most cited articles from the last journal are:

  • Novel Pathophysiological Mechanisms of Thrombosis in Myeloproliferative Neoplasms (5 citations)
  • Selecting the Optimal CAR-T for the Treatment of B-Cell Malignancies (3 citations)
  • MRD Assessment in Multiple Myeloma: Progress and Challenges. (2 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Current Hematologic Malignancy Reports (based on the number of publications) are:

  • Naveen Pemmaraju (12 papers) published 1 paper at the last edition the same number as at the previous edition,
  • Joseph D. Khoury (11 papers) published 1 paper at the last edition, 2 less than at the previous edition,
  • Ruben A. Mesa (10 papers) absent at the last edition,
  • Hagop M. Kantarjian (8 papers) absent at the last edition,
  • Vikas Gupta (7 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Current Hematologic Malignancy Reports (based on the number of publications) are:

  • University of Texas MD Anderson Cancer Center (78 papers) published 8 papers at the last edition, 4 more than at the previous edition,
  • Mayo Clinic (56 papers) published 4 papers at the last edition, 2 less than at the previous edition,
  • Harvard University (38 papers) published 3 papers at the last edition the same number as at the previous edition,
  • Memorial Sloan Kettering Cancer Center (28 papers) published 1 paper at the last edition, 1 less than at the previous edition,
  • Cleveland Clinic (28 papers) published 1 paper at the last edition, 3 less than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 1.89% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 40.38% were posted by at least one author from the top 10 institutions publishing in the journal. Another 21.15% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 25.00% of all publications and 13.46% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Top Publications

  • PD-1/PD-L1 Pathway and Its Blockade in Patients with Classic Hodgkin Lymphoma and Non-Hodgkin Large-Cell Lymphomas

    Wei Xie;Wei Xie;L. Jeffrey Medeiros;Shaoying Li;C. Cameron Yin

    (2020)
    68 Citations
  • Advances in the Diagnosis and Treatment of Large Granular Lymphocytic Leukemia.

    HeeJin Cheon;Karolina H. Dziewulska;Katharine B. Moosic;Kristine C. Olson

    (2020)
    49 Citations
  • Extramedullary Disease in Multiple Myeloma.

    Megan H Jagosky;Saad Z Usmani

    (2020)
    44 Citations
  • Advances in Risk Stratification and Treatment of Polycythemia Vera and Essential Thrombocythemia

    (2022)
    29 Citations
  • Management of Ibrutinib Toxicities: a Practical Guide

    Masa Lasica;Constantine S Tam;Constantine S Tam;Constantine S Tam

    (2020)
    29 Citations
  • Primary Cutaneous CD30+ Lymphoproliferative Disorders: a Comprehensive Review

    (2020)
    25 Citations
  • Germline CHEK2 and ATM Variants in Myeloid and Other Hematopoietic Malignancies

    (2022)
    24 Citations
  • Management of CNS Disease in Pediatric Acute Lymphoblastic Leukemia

    (2022)
    20 Citations
  • A Journey Through JAK Inhibitors for the Treatment of Myeloproliferative Diseases

    (2023)
    14 Citations
  • Towards a Personalized Definition of Prognosis in Philadelphia-Negative Myeloproliferative Neoplasms

    (2022)
    14 Citations

Related Online Degrees & Career Pathways

For students interested in Medicine in the USA, exploring related health science fields can broaden career options. One growing area is health information management, which combines healthcare knowledge with data management. Numerous health information management schools online offer affordable programs that prepare students to manage patient data securely and efficiently.

Nutrition is another vital field linked closely to medical science. Pursuing a cheapest online master's in nutrition can help healthcare professionals develop expertise in diet, wellness, and preventive care, enhancing their ability to support patient health.

Technical careers such as ultrasonography and radiology provide hands-on roles in diagnostic medicine. Those interested in imaging technologies can explore ultrasound tech school options to become certified ultrasound technicians. Similarly, online radiology tech programs offer accessible pathways to enter radiologic technology fields, essential for medical imaging and patient diagnosis.

These related online degrees enhance flexibility and affordability, making them popular choices for students seeking complementary careers in healthcare. By pursuing these programs, students can gain skills that support diverse, in-demand roles within the medical field.

Best Scientists Contributing to This Journal

Recently Published Articles